U.S. SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C.  20549
                                   FORM 10-QSB
(Mark  One)

[X]     QUARTERLY REPORT UNDER SECTION 13 OR 15(D) UNDER THE SECURITIES EXCHANGE
        ACT  OF  1934.

        For  the  quarterly  period  ended      March  31,  2000
                                            ---------------------

[  ]    TRANSITION  REPORT  UNDER  SECTION  13  OR  15(D)  OF THE EXCHANGE ACT.

        For  the  transition  period  from      to

                     Commission file number       000-28301
                                             --------------

                           ID TECHNOLOGIES CORPORATION
                           ---------------------------
        (Exact Name of Small Business Issuer as Specified in Its Charter)

     North  Carolina                                        56-1866233
     ---------------                                     ---------------
   (State  or  Other  Jurisdiction  of                   (I.R.S. Employer
   Incorporation or Organization)                        Identification No.)


                        920 Main Campus Drive / Suite 400
                          Raleigh, North Carolina 27606
                          -----------------------------
                    (Address of Principal Executive Offices)

                                 (919) 424-3722
                                 --------------
                (Issuer's Telephone Number, Including Area Code)

                                       N/A
                                       ---
                        (Former Name, Former Address and
                      Former Fiscal Year, if Changed Since
                                  Last Report)

     Check  whether  the  issuer:  (1) filed all reports required to be filed by
Section  13  or 15(d) of the Exchange Act during the past 12 months (or for such
shorter  period  that the registrant was required to file such reports), and (2)
has  been  subject  to  such  filing  requirements  for  the  past  90  days.
Yes     X      No
        -

     State  the  number of shares outstanding of each of the issuer's classes of
common  equity,  as  of  the  latest  practicable date: The issuer had 8,493,570
shares  of  common  stock  outstanding  as  of  May  5,  2000.
Transitional  Small  Business  Disclosure  Format  (check  one):
Yes           No     X
                     -



                                FORM 10-QSB INDEX

CAUTIONARY  STATEMENT  REGARDING  FORWARD  LOOKING  STATEMENTS

PART  I     FINANCIAL  INFORMATION
     ITEM  1.     FINANCIAL  STATEMENTS.
     ITEM  2.     MANAGEMENT'S  PLAN  OF  OPERATION.

PART  II    OTHER  INFORMATION
     ITEM  1.     LEGAL  PROCEEDINGS.
     ITEM  2.     CHANGES  IN  SECURITIES  AND  USE  OF  PROCEEDS.
     ITEM  3.     DEFAULTS  UPON  SENIOR  SECURITIES.
     ITEM  4.     SUBMISSION  OF  MATTERS  TO  A  VOTE  OF  SECURITY  HOLDERS.
     ITEM  5.     OTHER  INFORMATION.
     ITEM  6.     EXHIBITS  AND  REPORTS  ON  FORM  8-K.

SIGNATURES






CAUTIONARY  STATEMENT  REGARDING  FORWARD  LOOKING  STATEMENTS

          This  Form 10-QSB contains forward-looking statements.  Any statements
contained  in  this  Form  10-QSB that are not statements of historical fact are
intended  to  be  and are hereby identified as forward-looking statements within
the  meaning  of  the  Private  Securities  Litigation  Reform  Act of 1995.  ID
Technologies  Corporation,  a  North  Carolina  corporation  (the  "Company"  or
"IDTEK")  cautions  readers  that  forward  looking statements involve known and
unknown  risks and uncertainties which could cause actual results or outcomes to
differ  materially  from  those  expressed  in  the  forward-looking statements.
Forward-looking  statements  include  statements  concerning  plans, objectives,
goals,  strategies,  expectations,  future  events or performance and underlying
assumptions  and  other statements which are other than statements of historical
facts.

     Without  limiting  the  foregoing,  words  such as "may," "will," "expect,"
"believe,"  "anticipate,"  "estimate,"  "continue" or comparable terminology are
intended  to  identify  forward-looking  statements.  These  statements by their
nature  involve  substantial  risks  and  uncertainties,  and actual results may
differ  materially  depending  on  a  variety  of factors, many of which are not
within  the  Company's  control.  These factors include, but are not limited to,
economic  conditions  generally  and  in the industries in which the Company may
participate;  competition  within  the  Company's  chosen  industry,  including
competition from much larger competitors; technological advances; and failure by
the  Company  to  successfully  develop  potential  products  and/or  business
relationships and strategic alliances.  In addition to other factors and matters
discussed  elsewhere  herein,  the  following are important factors that, in the
view  of the Company, could cause actual results to differ materially from those
discussed  in  the  forward-looking statements: ability of the Company to obtain
acceptable forms and amounts of financing to fund current and future operations,
research  and development and acquisitions; competition; the Company's operating
losses; the Company's ability to commercially develop its proposed products; the
Company's  ability  to  attract,  hire  and  retain  employees  and  management
personnel; and the Company's  ability to regain control over the development and
exploitation  of its technology.  The Company disclaims any intent or obligation
to  update  these  forward-looking  statements,  whether  as  a  result  of  new
information,  future  events  or  otherwise.



                          PART I  FINANCIAL INFORMATION

ITEM  1.  FINANCIAL  STATEMENTS

<PAGE>

ID  TECHNOLOGIES  CORPORATION
(A  DEVELOPMENT  STAGE  COMPANY)
BALANCE  SHEETS


<TABLE>
<CAPTION>



                                                                           March 31, 2000        December 31, 1999
                                                                            (Unaudited)              (Audited)
                                                                      ------------------------  -------------------
<S>                                                                   <C>                       <C>
Assets
   Cash and cash equivalents . . . . . . . . . . . . . . . . . . . .  $                27,900   $            62,986
   Notes receivable. . . . . . . . . . . . . . . . . . . . . . . . .                    3,270                 3,270
   Prepaid expenses. . . . . . . . . . . . . . . . . . . . . . . . .                      150                   150
                                                                      ------------------------  -------------------
          Total current assets . . . . . . . . . . . . . . . . . . .                   31,320                66,406

   Equipment, net. . . . . . . . . . . . . . . . . . . . . . . . . .                    1,696                 1,884
   Patents, net. . . . . . . . . . . . . . . . . . . . . . . . . . .                   16,566                17,562
                                                                      ------------------------  -------------------
Total Assets . . . . . . . . . . . . . . . . . . . . . . . . . . . .  $                49,582   $            85,852
                                                                      ========================  ===================

Liabilities and Shareholders' Deficit
    Accounts payable and accrued liabilities . . . . . . . . . . . .                  141,810               122,260
    Note payable to shareholder. . . . . . . . . . . . . . . . . . .                   35,000                     -
    Convertible debt, net of discount of
      $114,000 and $171,000 at March 31,
      2000 and December 31, 1999,
       respectively. . . . . . . . . . . . . . . . . . . . . . . . .                  186,000               129,000
                                                                      ------------------------  -------------------
          Total current liabilities. . . . . . . . . . . . . . . . .                  362,810               251,260

   Deferred Revenue. . . . . . . . . . . . . . . . . . . . . . . . .                   93,000                93,000
   Long term convertible debt, net
      of discount of $30,512 and $34,166
      at March 31, 2000 and December 31,
      2000, respectively . . . . . . . . . . . . . . . . . . . . . .                  154,488               150,834

Shareholders' deficit:
   Series A Preferred stock, $.001 par
       value; 300,000 shares authorized;
       no shares issued and outstanding. . . . . . . . . . . . . . .                        -                     -
   Common stock, no par value,
       5,000,000 shares authorized;
       8,280,171 and 8,277,583 shares
       issued and outstanding at March
       31, 2000 and December 31, 1999,
       respectively. . . . . . . . . . . . . . . . . . . . . . . . .                  282,953               282,953
   Additional paid-in capital. . . . . . . . . . . . . . . . . . . .                3,406,034             3,390,859
   Deficit accumulated during
      the developmental stage. . . . . . . . . . . . . . . . . . . .               (4,249,703)           (4,083,054)
                                                                      ------------------------  --------------------
        Total shareholders' deficit. . . . . . . . . . . . . . . . .                 (560,716)             (409,242)
                                                                      ------------------------  --------------------
Total liabilities and sharehholders' deficit. . . . . . . . . . . .                   $49,582               $85,852
                                                                      ========================  ====================

</TABLE>




ID  TECHNOLOGIES  CORPORATION
(A  DEVELOPMENT  STAGE  COMPANY)
STATEMENTS  OF  OPERATIONS


<TABLE>
<CAPTION>


                                                                                  PERIOD FROM
                                                                                   INCEPTION
                                                                                   (MARCH 16,
                                         3 MONTHS ENDD       3 MONTHS ENDED       1994) THROUGH
                                         MARCH 31, 2000      MARCH 31, 1999       MARCH 31,2000
                                          (UNAUDITED)         (UNAUDITED)          (UNAUDITED)
                                      ------------------   ------------------  ------------------
<S>                                   <C>                  <C>                  <C>

License revenue . . . . . . . . . .          $ -                   $ -              $ 92,000
Research and development. . . . . .         10,000                68,000             673,668
Selling, general and
      administrative expenses . . .         84,314                37,907           3,504,486
                                     -------------------  ----------------------  ---------------
         Loss from Operations . . .        (94,314)             (105,907)         (4,086,154)
Other Income & Expense:
  Interest income - contractual . .            -                     -                 2,157
  Amortization of debt discount on.        (60,654)                  -              (127,358)
        convertible debentures
  Interest expense. . . . . . . . .        (11,681)               (2,110)            (38,348)
                                     -------------------  ----------------------  ---------------
                                           (72,335)               (2,110)           (163,549)
                                     -------------------  ----------------------  ---------------
Net Loss. . . . . . . . . . . . . .      $(166,649)            $(108,017)         $(4,249,703)
                                     ===================  ======================  ===============

Basic and diluted per common. . . .        $ (0.02)               $(0.01)
                                     ===================  ======================

Weighted average number
     of common shares . . . . . . .      8,277,729             8,175,833
                                     ===================  ======================
</TABLE>




ID  TECHNOLOGIES  CORPORATION
(A  DEVELOPMENT  STAGE  COMPANY)
STATEMENT  OF  SHAREHOLDERS'  EQUITY  (DEFICIT)
PERIOD  FROM  INCEPTION  (MARCH  16,  1994)  THROUGH  MARCH  31,  2000


<TABLE>
<CAPTION>

                                                                     DEFICIT
                                                       ADDITIONAL  ACCUMULATED
                                                        PAID-IN      DURING
                                SHARES       AMOUNT     CAPITAL    DEVELOPMENT    TOTAL
                              ----------  ------------  -------   -------------  --------
<S>                           <C>         <C>           <C>       <C>            <C>


Balance at March 16, 1994. .           -  $          -        -   $          -   $     -
Issuance of common shares
   for cash and noncash
   consideration . . . . . .   1,595,200           366       33              -       399
Net loss . . . . . . . . . .           -             -        -           (123)     (123)
                              ----------  ------------  -------   -------------  --------

Balance at December 31, 1994   1,595,200           366       33           (123)      276
Issuance of common shares
   for cash and noncash
    consideration. . . . . .     404,800             -      101              -       101
Net loss . . . . . . . . . .           -             -        -         (2,263)   (2,263)
                              ----------  ------------  -------   -------------  --------

Balance at December 31, 1995   2,000,000           366      134         (2,386)   (1,886)
</TABLE>



<TABLE>
<CAPTION>



                                                                                               DEFICIT
                                                                            ADDITIONAL       ACCUMULATED
                                                                             PAID-IN           DURING
                                            SHARES           AMOUNT          CAPITAL         DEVELOPMENT       TOTAL
                                       -----------------------------------------------------------------------------------
<S>                                      <C>              <C>            <C>               <C>            <C>
Issuance of common shares
   for cash and noncash
   consideration . . . . . . . . .        6,000,000        $        -       $    1,500      $          -      $     1,500
Net loss . . . . . . . . . . . . .                -                 -                -           (29,889)         (29,889)
                                       -------------------------------------------------------------------------------------

Balance at December  31, 1996. . .        8,000,000               366            1,634           (32,275)         (30,275)
Issuance of common shares
  for cash, net of
   issuance costs . . . . . . . . .         153,333           282,587                -                 -          282,587
Capital contribution in form
   of research and
   development services. . . . . .                -                 -          201,405                 -          201,405
Stock based compensation . . . . .                -                 -        1,333,600                 -        1,333,600
Net loss . . . . . . . . . . . . .                -                 -                -        (1,684,313)      (1,684,313)
                                      --------------------------------------------------------------------------------------

Balance at December  31, 1997. . .        8,153,333           282,953        1,536,639        (1,716,588)         103,004
Issuance of common shares
   for cash, net of
    issuance costs . . . . . . . .           22,500                 -           45,000                 -           45,000
Capital contribution in form
   of research and
   development services. . . . . .                -                 -          192,319                 -          192,319
Stock based compensation . . . . .                -                 -          933,425                 -          933,425
Net loss . . . . . . . . . . . . .                -                 -                -        (1,426,725)      (1,426,725)
                                     --------------------------------------------------------------------------------------

Balance at December 31, 1998 . . .        8,175,833           282,953        2,707,383        (3,143,313)        (152,977)
Issuance of warrants in connection
   with convertible debt . . . . .                -                 -          271,870                 -          271,870
Capital contribution in form
   of research and
   development services. . . . . .                -                 -          269,441                 -          269,441
Issuance of common shares
   for noncash consideration . . .          101,750                 -          142,165                 -          142,165
Net loss . . . . . . . . . . . . .                -                 -                -          (939,741)        (939,741)
                                     ---------------------------------------------------------------------------------------

Balance at December 31, 1999 . . .        8,277,583           282,953        3,390,859        (4,083,054)        (409,242)

Capital contribution in form
   of research and
   development services. . . . . .                -                 -           10,000                 -           10,000
Issuance of common shares
    for noncash consideration. . .            2,588                 -            5,175                 -            5,175
Net loss . . . . . . . . . . . . .                -                 -                -          (166,649)        (166,649)
                                    -----------------------------------------------------------------------------------------

Balance at March 31, 2000. . . . .        8,280,171        $  282,953  $     3,406,034      $ (4,249,703)     $  (560,716)
                                    =========================================================================================
</TABLE>






ID TECHNOLOGIES CORPORATION
(A DEVELOPMENT STAGE COMPANY)
STATEMENTS OF CASH FLOWS


<TABLE>
<CAPTION>


                                                                                                       PERIOD FROM
                                                                                                    INCEPTION (MARCH 16,
                                                   3 MONTHS ENDED         3 MONTHS ENDED              1994) THROUGH
                                                   MARCH 31, 2000         MARCH 31, 1999              MARCH 31, 2000
                                                    (UNAUDITED)             (UNAUDITED)                 (UNAUDITED)
                                                     -----------------------------------------------------------------
<S>                                                  <C>                 <C>                      <C>
Cash flows from operating activities:
Net loss. . . . . . . . . . . . . . . . . . . .  .  $(166,649)              $(108,018)               $(4,249,703)
Adjustments to reconcile net loss to
  net cash used in operation activities:
    Depreciation. . . . . . . . . . . . . . . . . .       188                     123                      1,579
    Amortization. . . . . . . . . . . . . . . . . .       996                     996                     11,337
    Deferred revenue. . . . . . . . . . . . . . . .      -                       -                        93,000
    Stock based compensation. . . . . . . . . . . .      -                       -                     2,267,025
    Noncash marketing expenses. . . . . . . . . . .      -                       -                        49,165
    Noncash development expenses. . . . . . . . . .    10,000                  68,000                    674,794
    Noncash professional fees . . . . . . . . . . .     5,175                    -                       143,175
    Discount on convertible debentures. . . . . . .    60,654                    -                       127,358
    Change in operating assets and liabilities:
          Notes receivable. . . . . . . . . . . . .      -                       -                        (3,270)
          Deposits. . . . . . . . . . . . . . . . .      -                       -                          (150)
          Accounts payable and accrued liabilities.    19,550                  15,072                    141,810
                                                     ------------------------------------------------------------------

Net cash used in operating activities . . . . . . .   (70,086)                (23,827)                  (743,880)

Cash flows from investing activities:
   Patent costs . . . . . . . . . . . . . . . . . .      -                       -                       (27,903)
   Purchase of equipment. . . . . . . . . . . . . .      -                       -                        (3,275)
                                                     ------------------------------------------------------------------

Net cash used in investing activities . . . . . . .      -                       -                       (31,178)

Cash flows from financing activities:
   Proceeds from note payable to shareholder. . . .    50,000                  20,000                    152,750
   Payment of note payable to shareholder . . . . .   (15,000)                   -                      (117,750)
   Financing costs
   Proceeds from sale of debentures . . . . . . . .      -                       -                       565,000
   Payment on convertible debt. . . . . . . . . . .      -                       -                       (80,000)
   Proceeds from issues of common shares, net . . .      -                       -                       282,958
                                                     -------------------------------------------------------------------

Net cash provided by financing activities . . . . .    35,000                  20,000                    802,958
                                                     -------------------------------------------------------------------
Increase in cash and cash equivalents . . . . . . .   (35,086)                 (3,827)                    27,900

Cash and cash equivalents, beginning of period. . .    62,986                   8,254                        -
                                                     -------------------------------------------------------------------
Cash and cash equivalents, end of period. . . . . .  $ 27,900                 $ 4,427                    $ 27,900
                                                     ===================================================================

</TABLE>




ID  TECHNOLOGIES  CORPORATION
(A  DEVELOPMENT  STAGE  COMPANY)
NOTES  TO  FINANCIAL  STATEMENTS
MARCH  31,  2000
(UNAUDITED)

1.  MANAGEMENT'S  OPINION
These  financial  statements  should  be  read  in  conjunction with the audited
consolidated  financial  statements  and notes thereto included in the Company's
Form  10K-SB  for  the  fiscal  year  ended  December  31,  1999.

2.  DEBT  DISCOUNT  AMORTIZATION
Substantially all of the debt discount amortization expense is a non-cash charge
to  account  for  the  value of the stock warrants granted to Centennial Venture
Partners  ("CVP") in conjunction with the $300,000 convertible debentures issued
in  September  1999. The warrants must be expensed over the one-year life of the
debt,  which  is due September 2000. The majority of the remaining debt discount
of  $144,512  will  be  amortized  during  the  remainder  of  fiscal year 2000.

Without the debt discount amortization, the net loss for the quarter ended March
31,  2000 would be $105,995, as compared to a net loss of $166,649, as reported.

3.   SHAREHOLDERS'  EQUITY  (DEFICIT)
In  March  2000,  the  Company  issued  2,588  shares of common stock, valued at
$5,175,  in  exchange  for  professional  services.


ITEM  2.  MANAGEMENT'S  PLAN  OF  OPERATION.

          The  Company  is engaged in the development of biometric technologies,
know-how,  and  products  for licensing worldwide.  The Company holds the patent
for  a  card, panel, or substrate allowing "on-board" storage and authentication
(identification) of fingerprints with a frontier biometric market size estimated
to  be  1/10 trillion dollars.  The applications of this technology are many and
varied: from welfare cards to loyalty/medical records/personal information cards
to  controlling  firearms  by  one  user.

     The development and production of this biometric breakthrough is managed by
the  Company's  scientific partner, Information Resources Engineering ("IRE") of
Baltimore, Maryland.  IRE is a leading provider of network and internet security
systems  and technologies.  IRE is a shareholder of the Company, owning 13.7% of
the  Company's  outstanding common stock.  IRE also holds a Company license with
rights to the internet, computer network, banking and treasury fields worldwide.

     A  prototype  card  was  completed  at the end of the Company's 1999 fiscal
year,  as  well  as  a  comprehensive  manufacturing plan to build a single-chip
production  card  at a cost below $20.  The non-recurring engineering cost (NRE)
will be paid by IRE to the production card maker at a cost of approximately $1.7
million.

     Presently,  the  Company  has  initial  licenses in place with IRE, Protek,
Power^Up Marketing Corporation, BrentScott Associates and Revolution Labs, which
are expected to yield $1.46 million in initial license fees when card production
begins.  Production  is  expected  to  begin  in  2000  or  2001.

     The  Company  believes  it  has  to  be the first-to-market leader with the
following  competitive  advantages:

-     A  biometric  fingerprint  card  with  storage and a power source (lithium
      battery)  on  board.
-     A  biometric  fingerprint  card not requiring an independent power source.
-     A  biometric fingerprint card safe-guarding personal privacy (a government
      or  corporate-based  database  system  is  unnecessary).
-     A  biometric fingerprint card with 160 m.p.s of computing power (the power
      of  a  Newton  computer).

The  biometric  fingerprint  card is essentially a standalone computer on a card
protected  by  the Lane foundation patent: United States Patent Number 5,623,552
issued  on  April  22,  1997.

          The  Company  has  been  a  developmental-stage  company  with nominal
revenues since its inception.  Losses were $1,426,725 in 1998, $939,741 in 1999,
$108,017  in  the quarter ended March 31, 1999 and $166,649 in the quarter ended
March  31,  2000.

     As  of  March  2000, the Company has depleted its cash. The Company's Chief
Executive  Officer  lent  the  Company  $50,000  in  March  2000  to support the
Company's  working  capital needs.  The Company is trying to raise at least $1.5
million  in  the immediate future with  $500,000 of that needed for current year
operations.

     With  the Company's policy of contracting out development and concentrating
on licensing of its intellectual property, the Company does not plan to purchase
any  equipment  or buy or rent plant(s) in the next year.  Nonetheless, when and
if the $1.5 million is raised, the Company intends to hire a high-level engineer
to  oversee  the  Company's  multi-development  card  projects  and  assist  the
Company's  licensees  with  their  particular  biometric  applications.

     RESULTS  OF  OPERATIONS

     The  following  discussion provides an analysis of the Company's results of
operations  and  liquidity  and  capital  resources.  This  should  be  read  in
conjunction with the financial statements of the Company and notes thereto.  The
operating  results  of  the periods presented were not significantly affected by
inflation.

COMPARISON  OF  THREE  MONTHS  ENDED  MARCH  31,  2000  AND  1999:

     There  was  no  license or royalty revenue for the three months ended March
31,  2000  or 1999.  License fee payments are predicated primarily on a $20 cost
biometric  fingerprint  production card.  Royalty payments are predicated on the
sale  of  the  cards  to  end-users  by  licensees.

     The  research  and  development  expenses  are  a  non-cash  entry  in both
quarters, which mirrors exactly IRE's research and development cash expenses for
the  development  of  the  biometric  fingerprint  card.  IRE's  research  and
development  cost  for the card was $10,000 for the three months ended March 31,
2000  compared to $68,000 for the three months ended March 31, 1999. Even though
IRE, the Company's development partner and 13.7% shareholder, is responsible for
and  incurred  this  expense,  ID Technologies must record the expense since the
Company  receives  the  benefits  from  IRE's  research.

     Selling, general, and administrative expenses during the three months ended
March  31,  2000  were $84,314, up 122% from the $37,907 of such expenses in the
prior  year quarter due to hiring a seasoned Chief Executive Officer in the fall
of  1999  and  the  necessary  purchase  of  Directors  and  Officers insurance.

     Amortization  of debt discount on convertible debentures was $60,654 in the
first  quarter  of  2000 compared to no such expense in the first quarter of the
1999  fiscal  year.  This is a non-cash expense to amortize the value of options
and  warrants associated with the $485,000 of convertible debt obtained in 1999.

     Interest  expense  was  $11,681  in  the first quarter of 2000, up from the
$2,110  recorded  in  the  first  quarter  of 1999.  This represents the accrued
interest  of  12%  on  $185,000 convertible debentures issued in mid-1999 and 8%
interest  on $300,000 convertible debentures issued in September 1999.  The only
debt  outstanding  in  the  first  quarter  of  1999  was  a  small  note from a
shareholder.

     The  Company's net operating loss for the three months ended March 31, 2000
was $94,314, down slightly from the net operating loss of $105,907 for the three
months  ended  March  31,  1999.

                          PART II     OTHER INFORMATION

ITEM  1.  LEGAL  PROCEEDINGS.

          The  Company  is not involved in any material pending legal proceeding
adverse  to  the  Company.

ITEM  2.     CHANGES  IN  SECURITIES  AND  USE  OF  PROCEEDS.

          There  were  no  sales  of common stock in the first quarter; however,
there  were  2,588  shares  issued  in  exchange  for  professional  services.

ITEM  3.     DEFAULTS  UPON  SENIOR  SECURITIES.

          There  is  no  debt due until September 2000 when the CVP note is due.
Other  debt  represents  a loan from a shareholder that has no defined due date.

ITEM  4.  SUBMISSION  OF  MATTERS  TO  A  VOTE  OF  SECURITY  HOLDERS.

          No  matters  were  submitted  to a vote of security holders during the
quarter  ended  March  31,  2000.

ITEM  5.     OTHER  INFORMATION.

          None.

ITEM  6.     EXHIBITS  AND  REPORTS  ON  FORM  8-K.



(A)     EXHIBITS.
        --------

<TABLE>
<CAPTION>


 Exhibit
   No.                    Description
----------   --------------------------------------------
<S>         <C>


 3.1         Articles of Incorporation, together with all
             amendments thereto.  (Incorporated herein
             by reference to Exhibit 2.01 of the
             Company's Form 10-SB filed as of
             November 30, 1999.)

 3.2         Bylaws.  (Incorporated herein by reference
             to Exhibit 2.02 of the Company's Form
             10-SB filed as of November 30, 1999.)

 4.1         Form of Debenture Purchase Agreement by
             and among the Company and purchasers of
             the Company's 12% Convertible
             Subordinated Debentures due 2002
             (Incorporated herein by reference to
             Exhibit 3.01 to the Company's Form 10
             -SB filed as of November 30, 1999.)

 4.2         Form of 12% Convertible Subordinated
             Debenture Due 2002. (Incorporated herein
             by reference to Exhibit 3.02 to the
             Company's Form 10-SB filed as of
             November 30, 1999.)

 4.3         Registration Rights Agreement, dated as of
             December 31, 1997, between the Company
             and Hutchison & Mason PLLC. (Incorporated
             herein by reference to Exhibit 3.04 to the
             Company's Form 10-SB filed as of November
             30, 1999.)

 4.4         Stock Purchase Agreement, dated as of August
             1, 1997, by and among the Company, Li-Pei
             Wu and William F. Lane (as agent for certain
             sellers), together with Addendum to Stock
             Purchase Agreement of even date therewith.
             (Incorporated herein by reference to Exhibit
             3.04 to the Company's Form 10-SB filed as
             of November 30, 1999.)

 4.5         Convertible Debenture, dated September 24,
             1999, made by the Company in favor of
             Centennial Venture Partners, LLC ("CVP").
             (Incorporated herein by reference to Exhibit
             3.05 to the Company's Form 10-SB filed as
             of November 30, 1999.)

 4.6         Common Stock Purchase Warrant, dated
             September 24, 1999, made by the Company
             in favor of CVP (450,000 shares). (Incorporated
             herein by reference to Exhibit 3.06 to the
             Company's Form 10-SB filed as of November
             30, 1999.)

 4.7         Common Stock Purchase Warrant, dated September
             24, 1999, made by the Company in favor of
             CVP (150,000 shares). (Incorporated herein
             by reference to Exhibit 3.07 to the Company's
             Form 10-SB filed as of November 30, 1999.)

 4.8         Common Stock Purchase Warrant, dated September
             24, 1999, made by the Company in favor of CVP
             (200,000 shares). (Incorporated herein by
             reference to Exhibit 3.08 to the Company's Form
             10-SB filed as of November 30, 1999.)

 4.9         Common Stock Purchase Warrant, dated September
             24, 1999, made by the Company in favor of CVP
             (up to $500,000). (Incorporated herein by
             reference to Exhibit 3.09 to the Company's Form
             10-SB filed as of November 30, 1999.)

 4.10        Investor Rights Agreement, dated as of September
             24, 1999, by and among the Company and certain
             holders of its capital stock.  (Incorporated herein by
             reference to Exhibit 3.10 to the Company's Form
             10-SB filed as of November 30, 1999.)

 4.11        Shareholders Agreement, dated September 24, 1999,
             by and among the Company and certain shareholders
             and investors.  (Incorporated herein by reference to
             Exhibit 3.11 to the Company's Form 10-SB filed as
             of November 30, 1999.)

 27          Financial Data Schedule.

</TABLE>





(b)     REPORTS  ON  FORM  8-K.

     On  February  11,  2000,  the  Company filed a report on Form 8-K reporting
under  Item  4  that  the Company changed independent public accountants for the
year  ended December 31, 1999 from PricewaterhouseCoopers, LLP to Ernst & Young,
LLP.

<PAGE>

                                   SIGNATURES


     In  accordance  with  the  requirements of the Exchange Act, the registrant
duly caused this report to be signed on its behalf by the undersigned, thereunto
duly  authorized.

                                                 ID  TECHNOLOGIES  CORPORATION



                                         BY     /S/  J.  Phillips  L.  Johnston
                                                --------------------------------
DATE:     May  15,  2000                         J.  Phillips  L.  Johnston,
                                                      President  and  CEO



                                                /S/  William  F.  Lane
                                                --------------------------------
DATE:     May  15,  2000                         William  F.  Lane, Chairman and
                                                          Treasurer
                                                 (Principal  Financial  Officer)